NCT01073904View on ClinicalTrials.gov

Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg

PHASE1CompletedINTERVENTIONAL

Enrollment

32

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

September 30, 2009

Study Completion Date

September 30, 2009

Conditions

Contraceptives, Postcoital

Interventions

DRUG

Levonorgestrel Emergency Pill (BAY86-5028)

Single dose of 1.5 mg coated tablet

DRUG

Postinor 2

Single dose of 1.5 mg tablet

Trial Locations (1)

58256

Morelia

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY

NCT01073904 - Cross-over Study to Prove Bioequivalence Between Two Oral Formulations of Levonorgestrel 1.5 mg | Biotech Hunter | Biotech Hunter